-
- Centrífugas de sobremesa
- Centrífugas de suelo
- Centrífugas refrigeradas
- Microcentrífugas
- Centrífugas multiuso
- Centrífugas de alta velocidad
- Ultracentrífugas
- Concentrador
- Productos IVD
- High-Speed and Ultracentrifuge Consumables
- Tubos de centrífuga
- Placas de centrífuga
- Gestión de dispositivos
- Gestión de muestras e información
-
- Pipeteo manual & dispensación
- Pipetas mecánicas
- Pipetas electrónicas
- Pipetas multicanal
- Pipetas de desplazamiento positivo y dispensadores
- Pipeteo automatizado
- Dispensadores de botella
- Controladores de pipeta
- Puntas de pipeta
- Consumibles de automatización
- Accesorios para dispensadores y pipetas
- Accesorios de automatización
- Servicios para dispensadores y pipetas
Read more
Read less
CAR-T Cells: Breakthroughs in Cancer and Auto-Immune Therapies
Leer más
Leer menos
CAR-T Cell Development – The Future of Fighting Cancer
CAR-T cells, genetically engineered and equipped with specific receptors to target and combat cancer cells, are primarily divided into two categories: autologous and allogenic CAR-T cells. Hereby, autologous CAR-T cells derive from the patient’s own white blood cells and are reintroduced after modification, whereas allogenic CAR-T cells are designed as off-the-shelf solutions for use in different patients. However, both approaches have their challenges. The manufacturing process for autologous CAR-T cells is complex and costly, as each patient’s cells must be individually processed. Allogeneic CAR-T cells, on the other hand, currently do not have the same safety profile, necessitating further research to address these issues.